000 01671 a2200457 4500
005 20250511214442.0
264 0 _c19900802
008 199008s 0 0 eng d
022 _a0031-9384
024 7 _a10.1016/0031-9384(90)90133-o
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGosnell, B A
245 0 0 _aEffects of preferential delta and kappa opioid receptor agonists on the intake of hypotonic saline.
_h[electronic resource]
260 _bPhysiology & behavior
_cMar 1990
300 _a601-3 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _a3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer
650 0 4 _aAnimals
650 0 4 _aDrinking
_xdrug effects
650 0 4 _aDynorphins
_xanalogs & derivatives
650 0 4 _aEating
_xdrug effects
650 0 4 _aEnkephalin, D-Penicillamine (2,5)-
650 0 4 _aEnkephalins
_xpharmacology
650 0 4 _aFood Preferences
_xdrug effects
650 0 4 _aHypotonic Solutions
650 0 4 _aInjections, Intraventricular
650 0 4 _aMale
650 0 4 _aOligopeptides
_xpharmacology
650 0 4 _aPeptide Fragments
_xpharmacology
650 0 4 _aPyrrolidines
_xpharmacology
650 0 4 _aRats
650 0 4 _aRats, Inbred Strains
650 0 4 _aReceptors, Opioid
_xdrug effects
650 0 4 _aReceptors, Opioid, delta
650 0 4 _aReceptors, Opioid, kappa
650 0 4 _aTaste
700 1 _aMajchrzak, M J
700 1 _aKrahn, D D
773 0 _tPhysiology & behavior
_gvol. 47
_gno. 3
_gp. 601-3
856 4 0 _uhttps://doi.org/10.1016/0031-9384(90)90133-o
_zAvailable from publisher's website
999 _c1978982
_d1978982